Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record now includes information about sharing individual participant data (IPD), including policy details, the plan for IPD sharing, and a URL for the policy.
    Difference
    0.4%
    Check dated 2026-09-12T18:03:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A funding line for 2019 (U.S. NIH Grant/Contract) has been added. The revision history now shows Revision: v3.6.6, replacing the previous v3.6.5 entry.
    Difference
    0.0%
    Check dated 2026-08-29T18:56:30.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The input indicates no changes to add or remove on the page; thus the page content remains as currently published.
    Difference
    0.0%
    Check dated 2026-08-22T16:27:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new Publication entry was added under Publications: Armstrong AW, Lebwohl M, Warren RB, Morita A, Paul C, Thaci D, Augustin M, Puig L, Daamen C, Li J, Alio A, Aggrey-Amable A, Scotto J, Popmihajlov Z, Vaile J, Strober B. Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials, Am J Clin Dermatol, 2026 Aug 7 (online ahead of print).
    Difference
    0.0%
    Check dated 2026-08-15T12:15:29.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's metadata/documentation. This appears to be a routine version bump rather than a change to study content or patient-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T08:56:24.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision line updated from v3.6.3 to v3.6.4, indicating a newer version in the page's revision history.
    Difference
    0.0%
    Check dated 2026-07-25T01:01:28.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.